4.7 Article

Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice

Journal

STEM CELL RESEARCH & THERAPY
Volume 8, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s13287-017-0699-7

Keywords

Silicosis; Cell therapy; Bone marrow mononuclear cells; Lung fibrosis; Inflammation

Funding

  1. Brazilian Council for Scientific and Technological Development (CNPq)
  2. Rio de Janeiro State Research Foundation (FAPERJ)
  3. Department of Science and Technology - Brazilian Ministry of Health (DECIT/MS)
  4. Coordination for the Improvement of Higher Education Personnel (CAPES)
  5. National Institute of Science and Technology for Regenerative Medicine (INCT/REGENERA)/CNPq

Ask authors/readers for more resources

Background: Administration of bone marrow mononuclear cells (BMMCs) modulates lung inflammation and fibrosis in experimental silicosis. However, no studies have evaluated whether silicosis affects the efficacy of autologous BMMCs treatment. We hypothesized that BMMCs obtained from healthy or silicotic mice may improve lung function, but they might affect the inflammatory and fibrotic processes differently in experimental silicosis. Methods: C57BL/6 mice were randomly divided into control (C) and silicosis (SIL) groups. Mice in the SIL group were instilled with silica particles intratracheally; the C animals received saline using the same protocol. On day 15, the animals were treated with saline (Sal) or BMMCs (2 x 10(6) cells) from healthy (BMMC-healthy) and silicotic (BMMC-sil) donors. Lung mechanics were measured, and lungs were collected for histology and molecular biology analysis. Results: BMMCs obtained from healthy and silicotic donors presented similar percentages of cell populations. Tc-99m-BMMCs tracking revealed preferential migration of cells to the liver, and only a few GFP(+) BMMCs were observed in lung tissue 24 h after treatment, regardless of donor type. Both the SIL-BMMC-healthy and SIL-BMMC-sil groups showed improvement in lung function, a reduction in the fractional area of granuloma, and a decrease in the number of mononuclear and apoptotic cells in lung parenchyma. In addition, the number of F4/80(+) macrophages, the levels of interleukin-1 beta and transforming growth factor beta, and collagen fiber content in granuloma were reduced in SIL-BMMC-healthy mice, whereas mRNA expression of MMP-9 and procollagen I and III was reduced in the SIL-BMMC-sil group. Conclusions: Administration of BMMCs from healthy and silicotic donors reduced lung inflammation and fibrosis, thus improving lung function. In addition, BMMC-healthy exhibited a greater improvement in lung morpho-functional changes in murine model of silicosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available